Come up with a name for your new list and we'll add to it:
Syndexa Pharmaceuticals raised a round of funding on May 22, 2008. Investors include
Dr. Yalcin Ayasli.
Syndexa Pharmaceuticals is dedicated to the discovery and development of drugs targeting biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes…